2016

10742 bookmarks
Custom sorting
Lyme disease and the pursuit of a clinical cure - PMC
Lyme disease and the pursuit of a clinical cure - PMC
Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne illness in the United States. Many aspects of the disease are still topics of controversy within the scientific and medical communities. One particular ...
·pmc.ncbi.nlm.nih.gov·
Lyme disease and the pursuit of a clinical cure - PMC
Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses - PubMed
Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses - PubMed
Around 10-20% of people who contract Lyme disease, the most common tickborne disease in the U.S., develop persistent, often debilitating symptoms such as chronic pain, fatigue, and cognitive dysfunction. Lyme infection-associated chronic illnesses (IACI) share symptoms common to other IACI such as L …
·pubmed.ncbi.nlm.nih.gov·
Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses - PubMed
Stevia Kills Lyme Disease Pathogen Better Than Antibiotics
Stevia Kills Lyme Disease Pathogen Better Than Antibiotics
Lyme disease is exceedingly difficult to treat, due to its well-known shape-shifting (pleomorphic) abilities, with conventional antibiotics often failing to produce a long-term cure. Could the commonly used natural plant stevia provide a safer, and more effective means to combat this increasingly prevalent infection?
·greenmedinfo.com·
Stevia Kills Lyme Disease Pathogen Better Than Antibiotics
Analysis of Polar Lipids in Hemp (Cannabis sativa L.) By-Products by Ultra-High Performance Liquid Chromatography and High-Resolution Mass Spectrometry - PMC
Analysis of Polar Lipids in Hemp (Cannabis sativa L.) By-Products by Ultra-High Performance Liquid Chromatography and High-Resolution Mass Spectrometry - PMC
Polar lipids were extracted from residual biomass of hemp (Cannabis sativa L.) by-products with EtOH and partitioned into aqueous and chloroform fractions. The chloroform fractions were studied for their lipid composition using solid-phase ...
·pmc.ncbi.nlm.nih.gov·
Analysis of Polar Lipids in Hemp (Cannabis sativa L.) By-Products by Ultra-High Performance Liquid Chromatography and High-Resolution Mass Spectrometry - PMC
Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: An update in experimental research - PubMed
Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: An update in experimental research - PubMed
Polyenylphosphatidylcholine (PPC) is a purified polyunsaturated phosphatidylcholine extract of soybeans. This article updates PPC's beneficial effects on various forms of liver cell injury and other tissues in experimental research. PPC downregulates hepatocyte CYP2E1 expression and associated hepat …
·pubmed.ncbi.nlm.nih.gov·
Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: An update in experimental research - PubMed
PhosChol PPC
PhosChol PPC
PhosChol PPC is the #1 healthcare professional brand of pharmaceutical grade polyenyl-phosphatidylcholine (PPC). Over 200 million doses have been administered by doctors in the United States alone. PhosChol is the highest concentrated source of active ingredient and is the Gold Standard PC for purity, and results.
·nutrasal.com·
PhosChol PPC
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
Researchers are increasingly focusing on understanding the microbiota’s influence on disease susceptibility and overall health. The vast number of microorganisms in our gastrointestinal tract and their extensive surface area underscore their ...
·pmc.ncbi.nlm.nih.gov·
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
Gut microbiome alterations are linked to various diseases, including neurodegeneration, but their ecological and functional impacts remain unclear. Using integrated multi-omics (metagenomics and metatranscriptomics), we analyse microbiome gene co-expression networks in Parkinson's disease (PD) and h …
·pubmed.ncbi.nlm.nih.gov·
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in
·x.com·
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
Build Apps with AI in Minutes | Base44
Build Apps with AI in Minutes | Base44
From idea to live app in minutes. Base44 gives you the tools to launch fully-functional apps - no code, no setup, no hassle.
·base44.com·
Build Apps with AI in Minutes | Base44